JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme

NCT00311402 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1295
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boehringer Ingelheim